CUSIP: 30050BAB7
What is CUSIP 30050BAB7?
CUSIP 30050BAB7 identifies 30050BAB7 - EVOLENT HEALTH INC - NOTE 2.000%12/0 in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 30050BAB7:
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2021 Q4 | $0 | $0 | -$33,639,000 | 0 | |
| 2021 Q3 | $26,185,000 | $33,639,000 | +$221,457 | 120.8% | 11 |
| 2021 Q2 | $26,026,000 | $27,577,000 | +$1,568,000 | 109.4% | 11 |
| 2021 Q1 | $24,597,000 | $26,456,000 | -$1,424,909 | 107.67% | 10 |
| 2020 Q4 | $25,961,000 | $26,249,000 | -$85,000 | 100.0% | 10 |
| 2020 Q3 | $13,547,000 | $13,348,000 | -$90,202,917 | 98.27% | 10 |
| 2020 Q2 | $117,046,000 | $102,101,486 | +$10,056,336 | 87.4% | 19 |
| 2020 Q1 | $102,252,420 | $92,978,462 | +$9,038,030 | 86.21% | 18 |
| 2019 Q4 | $90,533,746 | $84,691,027 | +$16,762,141 | 90.0% | 17 |
| 2019 Q3 | $71,976,420 | $66,016,000 | +$1,677,379 | 87.55% | 15 |
| 2019 Q2 | $74,038,087 | $70,646,465 | -$1,982,851 | 88.71% | 19 |
| 2019 Q1 | $74,831,424 | $77,991,181 | -$14,890,628 | 97.04% | 21 |
| 2018 Q4 | $81,180,004 | $103,773,712 | +$1,142,315 | 110.92% | 23 |
| 2018 Q3 | $76,431,000 | $119,960,047 | +$4,267,922 | 135.17% | 17 |
| 2018 Q2 | $72,983,000 | $97,741,063 | +$22,933,662 | 113.9% | 16 |
| 2018 Q1 | $66,607,000 | $67,033,000 | +$2,541,370 | 100.28% | 12 |
| 2017 Q4 | $64,318,000 | $61,470,000 | +$61,470,000 | 95.12% | 12 |